
 |
| MedicineNet.com: Medical Dictionary |
 |
 |
|
|
United States |
|
An explanation of what cleidocranial dysplasia is and how it is transmitted.
|
 |
| Url: |
|
| Desc: |
Health and Medical Information produced by doctors - MedicineNet.com
|
| |
Doctor-produced health and medical information written for you to make informed decisions about your health concerns.
|
| Category: |
Conditions and Diseases\ Rare Disorders
|
| Link Error: |
Report It
|
| |
|
|
|
| Related Site |
 |
 |
Moyamoya Disease : Support group for those diagnosed with this condition and their families. Includes medical information, personal account, links and a message board.
Progeria Research Foundation, Inc. : Medical research, education, support, and fundraising for this "pre-mature aging" disease.
University of Washington: Werner Syndrome : Images of persons with this disease and diagnostic criteria for WRN and contact information for a central repository of WS data and research and materials.
Rubinstein-Taybi Syndrome : A site devoted to the families and people diagnosed with this syndrome.
Cystinosis Research Network : Information about the organization and their mission. Extensive database about the disease as well as support groups, research and links to other resources.
Zoe Lambert : Personal account of this condition, and surgery to receive titanium rib implants.
National PKU News : Site includes news and information about phenylketonuria, a rare inherited metabolic disease.
Cystinosis Central : Information about this disorder, conferences, data for physicians, updates and links.
Human Growth Foundation : Information about growth-related disorders through education, research, and advocacy. Member driven organization.
ALtruis Biomedical Network : Information on the types, causes and treatments of pemphigus.
|
|
|
 |
 |
 |
Approval Expanded for Breast Cancer Drug Tykerb (HealthDay)
HealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded approval for Tykerb (lapatinib) to include
postmenopausal women with hormone- and HER2-positive advanced breast
cancer who require hormone therapy. |
|
|
 |